WHC is still in active development. Read this to understand our approach.
depiction of HHVUFQYJOSFTEH-UHFFFAOYSA-N.svg
isomerdesign

URB-602

Verificar en isomerdesign

drugmap

Biphenyl-3-ylcarbami...

Verificar en drugmap

wiki

URB602

Verificar en wiki

Data

InChI: InChI=1S/C19H21NO2/c21-19(22-18-12-5-2-6-13-18)20-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,18H,2,5-6,12-13H2,(H,20,21)

Sinónimos: URB 602, N-[1,1'-Biphenyl]-3-yl-carbamic Acid Cyclohexyl Ester, biphenyl-3-ylcarbamic acid cyclohexyl ester, SCHEMBL4274165, CTK8C4433,URB602, DTXSID90450611, BDBM50128581,URB-602, CHEMBL77767, URB602,565460-15-3, Monoacylglycerol Lipase Inhibitor, URB602, ZINC13520725, Cyclohexylbiphenyl-3-ylcarbamate, BCP19101, ANW-71925, B8371SFA9K, MolPort-003-850-812, Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate, cyclohexyl biphenyl-3-ylcarbamate, URB-602, UNII-B8371SFA9K, N-Biphenyl-3-ylcarbamic acid, cyclohexyl ester, HHVUFQYJOSFTEH-UHFFFAOYSA-N, EX-A1228,Cyclohexyl-[1,1'-biphenyl]-3-ylcarbamate

Estimated data

Solubilidad: -4.978 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 47.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.